Inhaled nitric oxide therapy in neonates and children: reaching a European consensus.
Intensive Care Med
; 30(3): 372-80, 2004 Mar.
Article
em En
| MEDLINE
| ID: mdl-14722629
ABSTRACT
Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently been used extensively in the management of neonates and children with cardiorespiratory failure. This paper assesses evidence for the use of iNO in this population as presented to a consensus meeting jointly organised by the European Society of Paediatric and Neonatal Intensive Care, the European Society of Paediatric Research and the European Society of Neonatology. Consensus Guidelines on the Use of iNO in Neonates and Children were produced following discussion of the evidence at the consensus meeting.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Broncodilatadores
/
Óxido Nítrico
Tipo de estudo:
Guideline
/
Qualitative_research
Limite:
Child
/
Humans
/
Newborn
Idioma:
En
Revista:
Intensive Care Med
Ano de publicação:
2004
Tipo de documento:
Article
País de afiliação:
Reino Unido